肝靶向给药系统的研究进展(4)

http://www.100md.com 2010年3月25日 《中国当代医药》 2010年第9期

     [21]李锦娟,杨广德,王红英,等.氟尿苷二丁酸酯固体脂质纳米粒的制备和肝靶向性研究[J].药学学报,2008,43(7):761-765.

    [22]孙洁胤,周芝芳,刘放,等.苦参素固体脂质纳米粒的药动学和体内分布[J].中国药学杂志,2007,42(14):1091-1095.

    [23]何林,李素华,吴正中,等.肝靶向阿克拉霉素A固体脂质纳米粒质量考察及体内分布研究[J].中国药学杂志,2008,43(63):431-435.

    [24]Hoell A,Wiedenmann A,Heyen U,et al.Nanostructure and eld- induced arrangement of magnetosomes studied by SANSPOL[J].Physica B,2004,350(1-3):309-313.

    [25]Grunberg K,Muller EC,Otto A,et al.Biochemical and proteomic analysis of the magnetosome membrane in magnetospirillum gryphiswaldense[J].Appl.Environ.Microbiol,2004,70(2):1040-1050.

    [26]Sun JB,Duan JH,Dai SL,et al.In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells:The magnetic bio-nanoparticles as drug carriers[J].Cancer Letters,2007,258(1):109-117.

    [27]王钦,胡玮,张学农,等.去甲斑蝥素N-乳糖酰壳聚糖纳米粒的制备及其特性研究[J].中草药,2009,40(1):40-45.

    [28]Watanabe T,Umeharal T,Yasui F,et al.Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome[J].Journal of Hepatology,2007,47(6):744–750.

    [29]聂常富,陈规划,李华,等.肝靶向性Gal-PEG-PEI纳米载体介导psiRNA转染HepG2细胞效率的检测[J].中华实验外科杂志,2009,26(8):1015-1017.

    (收稿日期:2010-02-22)(贺 玲 李健和)

上一页 第 1 2 3 4 页

    百拇医药网 http://www.100md.com/html/paper/1674-4721/2010/09/11-3.htm